You are here: Industry Insights > NHS

News List

Communications Team of the Year: Finalists announced as countdown to awards evening begins! pharmatimes
November 01, 2018
The competition continues to go from strength to strength - and this year was fiercely contested with over 20 companies trying to be crowned Communications Team of the Year 2018.
Merck KGaA's Mavenclad, Roche's Perjeta win 'innovative' coverage deals with NHS fiercepharma
November 13, 2017
Roche has also had issues winning coverage for some of its other new cancer drugs in the U.K., such as Tecentriq and Kadcyla.
NICE recommends Bristol-Myers Squibb’s nivolumab for NSCLC patients on NHS pharmaceufical-technology
September 22, 2017
PD-L1 is involved in the body’s immune response to cancer and nivolumab demonstrates better effectiveness in patients who have more PD-L1 protein on their cancer cells.
GP leaders warn of ‘break-point’ for the profession pharmatimes
August 01, 2017
GP leaders are warning that the profession will reach break point unless progress on certain elements of the GP Forward View is accelerated
Lords request new body to lead NHS sustainability pharmatimes
April 07, 2017
The Select Committee on the Long-term Sustainability of the NHS has slammed successive governments’ ongoing ...
NICE approves former CDF kidney cancer drug for NHS use europeanpharmaceuticalreview
January 13, 2017
The National Institute for Health and Care Excellence (NICE), in new draft guidance, has recommended everolimus for treating some people with advanced kidney cancer, a drug which was previously only available through the Cancer Drugs Fund (CDF).